ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

RFA, “New Approaches In Surgical Oncology” Announced By DCT

December 1, 1978

DCBD Okays Concept For Molecular Probes In Colon Cancer, Two Other Organ Systems Generated Projects

July 4, 1986

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

NCI’s Hawk To Lead Prevention Division At M.D. Anderson.

November 16, 2007

Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients

November 30, 2012

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

November 16, 1979